{"changes":[],"country":"US","description":"Endeavor BioMedicines is a clinical-stage biotechnology company developing medicines for life-threatening fibrotic and oncology diseases. It serves patients with conditions such as idiopathic pulmonary fibrosis through taladegib, a Hedgehog pathway inhibitor. Its pipeline also includes ENV-501, an antibody-drug conjugate targeting fibrosis.","domain":"endeavorbio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech|therapeutics|pulmonary","investors":["gv"],"lat":32.716692,"lng":-117.169295,"location":"San Diego CA","name":"Endeavor BioMedicines","rounds":[{"amountQuarantined":false,"amountUsd":132500000,"currency":"USD","date":"2024-04-01","investors":["gv"],"leadInvestor":"gv","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-20","status":"attributed","url":null},"status":"attributed","type":"series-c","url":null}],"slug":"endeavorbio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-20","status":"attributed","url":null},{"fact":"existence","publisher":"endeavorbio.com","retrievedAt":"2026-05-20","status":"self-reported","url":"https://endeavorbio.com"},{"fact":"description","publisher":"endeavorbio.com","retrievedAt":"2026-05-20","status":"self-reported","url":"https://endeavorbio.com"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":132500000,"updatedAt":"2026-05-20"}